Oncternal Therapeutics Inc. (ONCT) Misses Q1 EPS by 283c

Oncternal Therapeutics Inc. (NASDAQ: ONCT) reported Q1 EPS of ($2.83). Revenue for the quarter came in at $570 thousand.

For earnings history and earnings-related data on Oncternal Therapeutics Inc. (ONCT) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Boost Run, Inc. (BRUN) Reports Q2 Revenue of $31.1M
• Tvardi Therapeutics (TVRD) Tops Q2 EPS by 1c